Consistent with this our previous work demonstrated that knockdown of either CLDN3 or CLDN4 produced marked changes in the phenotype of putative human ovarian cancer cells that include increased growth rate in vivo, enhanced cell motility and metastatic potential as well as resistance to platinum-containing drugs, all of which are EMT-related characteristics [29]. Here, CLDN3 is linked to ovarian carcinoma.